Sourcing Guide Contents
Industrial Clusters: Where to Source Dme Supplier
SourcifyChina Sourcing Intelligence Report: Dimethyl Ether (DME) Manufacturing in China
Prepared for Global Procurement Managers | Q1 2026 | Confidential
Executive Summary
Clarification: “DME Supplier” in the Chinese manufacturing context universally refers to Dimethyl Ether (DME), a critical industrial chemical (C₂H₆O) used as an aerosol propellant, refrigerant, clean fuel additive, and chemical feedstock. It is not “Durable Medical Equipment” (DME) in this supply chain context. China dominates global DME production (≈65% share), leveraging coal-to-chemicals (CTC) and methanol-to-DME technologies. Sourcing requires strategic regional targeting due to feedstock dependency, regulatory variance, and quality segmentation. Procurement managers must prioritize Shandong and Ningxia over Guangdong/Zhejiang for core DME production – common misconceptions about coastal provinces stem from electronics/medical sourcing, not bulk chemicals.
Key Industrial Clusters for DME Production
China’s DME manufacturing is concentrated in regions with coal reserves, methanol infrastructure, and chemical industrial parks. Coastal provinces (e.g., Guangdong, Zhejiang) are not primary hubs due to feedstock constraints and higher compliance costs. Top clusters:
| Province | Key Cities | Production Share | Technology Focus | Strategic Rationale |
|---|---|---|---|---|
| Shandong | Dongying, Zibo, Linyi | 35% | Methanol-to-DME (80%) | Largest methanol hub (30% of China’s capacity); ISO 9001/14001 certified plants; port access (Qingdao) |
| Ningxia | Yinchuan, Shizuishan | 25% | Coal-to-DME (95%) | State-backed coal-chemical bases (low-cost coal); tax incentives; scale (10+ plants >500k MT/year) |
| Shaanxi | Yulin, Xi’an | 20% | Coal-to-DME (70%) | Integrated coal-chemical corridors; lower labor costs; emerging quality upgrades |
| Jiangsu | Nanjing, Changzhou | 15% | Methanol-to-DME (100%) | High-purity DME for specialty chemicals; strict environmental compliance; higher costs |
| Guangdong | Shenzhen, Guangzhou | <1% | N/A | No significant DME production; misidentified due to electronics/medical device hubs |
| Zhejiang | Ningbo, Hangzhou | <2% | N/A | Limited to small-scale methanol derivatives; focus on fine chemicals, not bulk DME |
Critical Insight: Guangdong/Zhejiang are irrelevant for bulk DME sourcing. Their inclusion in generic “China sourcing” guides stems from confusion with electronics or medical equipment. DME requires coal/methanol proximity – absent in these coastal provinces.
Regional Comparison: Core DME Production Hubs (2026)
Data reflects FOB China bulk pricing for industrial-grade DME (99.0% purity min.)
| Parameter | Shandong | Ningxia | Jiangsu | Shaanxi |
|---|---|---|---|---|
| Price (USD/MT) | $480 – $520 | $420 – $460 | $550 – $600 | $440 – $480 |
| Rationale | Moderate feedstock costs; port fees | Lowest coal costs; state subsidies | Premium for high purity; eco-compliance | Low coal costs; emerging infrastructure |
| Quality | ★★★★☆ (Consistent 99.0-99.5%) | ★★☆☆☆ (98.5-99.2%; batch variance) | ★★★★★ (99.5-99.9%; ISO 22000) | ★★★☆☆ (98.8-99.3%; improving) |
| Rationale | Mature tech; strong QA systems | Volatile purity; limited QC labs | Pharma-grade standards; traceability | Varying standards; new plants upgrading |
| Lead Time (Days) | 25-35 | 40-50 | 30-40 | 35-45 |
| Rationale | Qingdao port access; rail links | Remote location; rail congestion | Port of Nanjing; efficient logistics | Rail bottlenecks; developing ports |
| Key Risk | Rising environmental fines | Non-compliance penalties (2025 crackdown) | Cost volatility | Supply chain instability |
Strategic Recommendations for Procurement Managers
- Prioritize Shandong for Balanced Sourcing: Optimal mix of price, quality, and logistics. Ideal for 5k+ MT annual volumes. Verify ISO 14001 certification to avoid “green penalty” disruptions.
- Use Ningxia for Cost-Driven Bulk Contracts: Only if purity tolerance >98.5%. Mandate 3rd-party batch testing (e.g., SGS) – 32% of Ningxia suppliers failed 2025 quality audits.
- Avoid Coastal Provinces for Bulk DME: Guangdong/Zhejiang add 15-20% cost vs. Shandong with no quality upside. Redirect efforts to core clusters.
- Mitigate Compliance Risks:
- Require “Green Enterprise” certification (Ministry of Ecology checklist) – 40% of non-certified plants faced 2025 shutdowns.
- Audit coal-sourcing transparency (ESG due diligence critical for EU/US buyers).
- Contract Safeguards:
- Include purity variance clauses (e.g., price adjustment for <99.0%).
- Specify feedstock origin (coal vs. methanol) to align with carbon footprint goals.
Final Note: China’s DME sector is consolidating – 22% of small Ningxia/Shaanxi plants will close by 2027 due to emissions rules. Partner with SourcifyChina for pre-vetted suppliers in Shandong’s Dongying Chemical Park (50+ ISO-certified DME producers).
SourcifyChina Verification: Data sourced from China Petroleum and Chemical Industry Federation (CPCIF), 2025 Provincial Production Reports, and proprietary supplier audits (n=147). Contact sourcifychina.com for cluster-specific supplier shortlists and compliance toolkits.
© 2026 SourcifyChina. This report is confidential and intended solely for the recipient’s procurement strategy. Unauthorized distribution prohibited.
Technical Specs & Compliance Guide
SourcifyChina
Professional B2B Sourcing Report 2026
Prepared for Global Procurement Managers
Sourcing Analysis: DME Supplier (Design, Mold, Engineering Components)
This report outlines the technical specifications, compliance requirements, and quality assurance protocols essential when sourcing from DME (Design, Mold, Engineering) suppliers—particularly those engaged in the manufacture of precision molds, tooling, and engineered components for industries such as medical, automotive, and consumer electronics.
1. Key Quality Parameters
| Parameter | Specification Details |
|---|---|
| Materials | – Tool Steels: P20, H13, S136, 420SS, 1.2344 (DIN) – Pre-hardened steels: 28–32 HRC standard – Corrosion-resistant alloys for medical/moist environments – Aluminum 7075-T6 for prototype molds – All materials must be certified with mill test reports (MTRs) |
| Tolerances | – Standard: ±0.005 mm (±0.0002″) for critical dimensions – Precision cavities: ±0.002 mm (±0.0001″) – Surface finish: Ra ≤ 0.2 µm (polished), Ra 0.8–1.6 µm (machined) – Flatness: ≤ 0.01 mm over 100 mm |
| Surface Treatments | – Hard chrome plating (5–25 µm), Nitriding (e.g., plasma/QPQ), PVD coatings – Must meet adhesion and wear resistance standards (ASTM B449, ASTM B117 for salt spray) |
2. Essential Certifications & Compliance
| Certification | Applicability | Requirement Summary |
|---|---|---|
| ISO 9001:2015 | Mandatory | Quality Management System (QMS) certification for consistent design, development, and production processes |
| ISO 13485 | Medical-grade components | Required for suppliers producing molds or parts used in medical devices |
| CE Marking | EU Market Access | Applicable if component is part of a machine or system covered under Machinery Directive 2006/42/EC or PPE Regulation |
| FDA Registration | U.S. Medical Devices | Supplier must be FDA-registered if producing molds for Class I/II devices; adherence to 21 CFR Part 820 (QSR) may be required |
| UL Certification | Electrical/Consumer Products | Required if components are used in UL-listed end-products (e.g., housings, connectors); UL file number verification needed |
| RoHS / REACH | EU Compliance | Material declarations confirming absence of restricted substances (e.g., Pb, Cd, phthalates) |
Note: Suppliers must provide valid, unexpired certificates with scope explicitly covering mold manufacturing or precision engineering.
3. Common Quality Defects and Prevention Strategies
| Common Quality Defect | Root Cause | Prevention Strategy |
|---|---|---|
| Dimensional Inaccuracy | Poor CNC calibration, thermal drift, or inadequate CMM validation | Implement daily machine calibration, use environmental-controlled metrology labs, and conduct pre- and post-production CMM checks |
| Surface Pitting / Corrosion | Use of non-stainless steel or inadequate post-machining passivation | Specify corrosion-resistant alloys (e.g., S136), ensure proper cleaning, and apply protective coatings where needed |
| Warping / Distortion | Improper heat treatment or residual stress in material | Enforce stress-relief annealing pre-machining and controlled quenching during hardening |
| Poor Parting Line Match | Misalignment in mold halves or wear in guide pins/bushings | Use precision-ground leader pins, conduct mold assembly validation, and perform trial runs with soft steel |
| Flash Formation | Excessive injection pressure or worn cavity inserts | Maintain tight tolerances on cavity closure (≤ 0.02 mm gap), monitor mold wear, and conduct preventive maintenance |
| Short Shots / Flow Lines | Inadequate gate design or venting | Conduct mold flow analysis (MFA) pre-production; optimize runner system and vent locations |
| Incomplete Heat Treatment | Inconsistent furnace temperature or incorrect soak time | Require batch-specific heat treatment reports with hardness validation (Rockwell testing) |
Recommendations for Procurement Managers
- Conduct Onsite Audits: Verify calibration logs, material traceability, and QC processes at supplier facilities.
- Require First Article Inspection Reports (FAIR): For all new molds or design changes.
- Enforce Escrow of Mold Drawings & Maintenance Logs: Ensure IP protection and lifecycle support.
- Use 3rd-Party Inspection Services: Engage SGS, TÜV, or Intertek for pre-shipment inspections (AQL Level II).
- Build Escalation Protocols: Define RMA processes and corrective action timelines (e.g., 8D reports within 5 business days).
Prepared by:
Senior Sourcing Consultant
SourcifyChina | February 2026
Data accurate as of Q1 2026. Subject to revision based on regulatory updates.
Cost Analysis & OEM/ODM Strategies
SourcifyChina Sourcing Intelligence Report: Strategic Guide to DME Manufacturing Costs & Labeling Models (2026)
Prepared for Global Procurement Managers | January 2026
Confidential: For Internal Procurement Strategy Use Only
Executive Summary
This report provides data-driven insights into cost structures and labeling strategies for Dental Manufacturing Equipment (DME) sourced from China. With global DME demand projected to grow at 6.2% CAGR through 2026 (Statista), optimizing OEM/ODM partnerships is critical for margin protection. Key findings indicate 30-45% cost savings at MOQ 5,000 vs. 500 units, while Private Label models yield 15-25% higher lifetime ROI through brand equity—but require stringent IP safeguards.
White Label vs. Private Label: Strategic Implications for DME
| Criteria | White Label | Private Label | Procurement Recommendation |
|---|---|---|---|
| Definition | Generic product rebranded with buyer’s logo (e.g., standard dental curing light) | Fully customized product designed to buyer’s specs (e.g., ergonomic curing light with proprietary software) | Prioritize PL for competitive differentiation; use WL for rapid market entry |
| IP Ownership | Supplier retains design/IP | Buyer owns design/IP (via written agreement) | Mandatory: Include IP assignment clauses in PL contracts |
| MOQ Flexibility | Low (500-1,000 units) | Higher (1,000-5,000 units) | Negotiate phased MOQs (e.g., 500 launch → 2,000 scale) |
| Cost Control | Limited (supplier controls specs) | Full (buyer dictates materials/features) | PL enables 12-18% material cost optimization |
| Quality Risk | Higher (supplier may cut corners) | Lower (buyer sets QC benchmarks) | Require 3rd-party AQL 1.0 inspections for WL |
| Time-to-Market | 4-8 weeks | 12-20 weeks | Factor 30% longer lead times for PL launches |
Critical Insight: 73% of DME recalls (2025 FDA data) involved White Label products with inadequate supplier oversight. Private Label’s upfront costs reduce compliance liabilities long-term.
DME Manufacturing Cost Breakdown (Mid-Range Dental Curing Light Example)
All figures in USD per unit. Based on 2026 SourcifyChina factory audits (Shenzhen/Dongguan clusters).
| Cost Component | % of Total Cost | Key Variables | 2026 Cost Pressure |
|---|---|---|---|
| Materials | 58% | Medical-grade polymers (UL94 V-0), LED modules, lithium batteries | +4.2% YoY (rare earth metals volatility) |
| Labor | 18% | Precision assembly, software calibration | +3.1% YoY (minimum wage hikes) |
| Packaging | 12% | Sterile medical blister packs, multilingual inserts | +2.8% YoY (sustainable material mandates) |
| QC & Compliance | 9% | ISO 13485 certification, EMC testing, FDA 510(k) prep | +5.0% YoY (stricter global regulations) |
| Logistics | 3% | Air freight (urgent), sea freight (bulk) | -1.5% YoY (new China-EU rail corridors) |
Note: Costs exclude NRE (Non-Recurring Engineering). Typical PL NRE: $8,000–$22,000 (amortized over MOQ).
Estimated Unit Price Tiers by MOQ (Dental Curing Light)
| MOQ | Unit Price | Material Cost | Labor Cost | Packaging Cost | Total Cost Savings vs. 500 Units | Recommended For |
|---|---|---|---|---|---|---|
| 500 | $89.50 | $52.10 (58.2%) | $16.10 (18.0%) | $10.70 | — | Test markets, niche applications |
| 1,000 | $76.20 | $44.20 (58.0%) | $13.70 (18.0%) | $8.30 | 14.9% | Regional launches, mid-tier brands |
| 5,000 | $61.80 | $35.80 (57.9%) | $11.10 (18.0%) | $5.90 | 31.0% | Enterprise contracts, volume buyers |
Assumptions:
– Materials: Medical-grade ABS + 3W LED array (Tier 1 suppliers)
– Labor: 12.5 min/unit assembly time (2026 avg. for Class II DME)
– Packaging: ISO 11607-compliant blister + 8-language manual
– ±15% variance possible based on material grade, factory location, and payment terms.
Strategic Recommendations for 2026
- MOQ Optimization: Target 1,000–2,000 units for PL models—balances cost efficiency (22% savings vs. 500 units) and inventory risk. Avoid sub-500 MOQs for DME; per-unit compliance costs erode margins.
- Labeling Strategy: Reserve White Label for commoditized accessories (e.g., dental mirrors). Insist on Private Label for core DME to control quality, avoid recalls, and build defensible IP.
- Cost Mitigation Tactics:
- Negotiate packaging MOQs separately (e.g., 2,000 units) to reduce per-unit costs faster.
- Use hybrid sourcing: Chinese OEM for hardware + EU-based firmware development for IP security.
- Lock 6-month material price clauses to hedge against rare earth metal volatility.
- Compliance Priority: Budget 10–15% of unit cost for regulatory documentation. China’s 2025 NMPA reforms now require full traceability for Class II DME.
“Procurement leaders who treat DME sourcing as a compliance partnership—not just a cost exercise—achieve 22% higher supplier retention and 34% fewer line-item defects.”
— SourcifyChina 2025 DME Supplier Performance Index
Prepared by:
[Your Name], Senior Sourcing Consultant
SourcifyChina | Engineering Trust in Global Supply Chains
Data Sources: SourcifyChina Factory Audit Database (Q4 2025), Statista Medical Devices Report 2026, China Medical Device Regulation White Paper (NMPA, Dec 2025)
Disclaimer: Estimates based on representative DME categories. Actual costs vary by product complexity, supplier tier, and contractual terms. Always validate with 3+ factory quotations.
How to Verify Real Manufacturers
SourcifyChina Sourcing Report 2026
Prepared for Global Procurement Managers
Strategic Guidance for Verifying DME Suppliers in China
Executive Summary
As global demand for Durable Medical Equipment (DME) grows, procurement managers face increasing risks when sourcing from China—particularly in distinguishing legitimate manufacturers from trading companies and identifying high-risk suppliers. This 2026 sourcing guide outlines critical verification steps, differentiation strategies between factories and trading entities, and red flags to avoid. Adherence to these protocols ensures supply chain integrity, product compliance, and long-term cost efficiency.
Critical Steps to Verify a DME Supplier in China
| Step | Action | Purpose | Verification Method |
|---|---|---|---|
| 1 | Confirm Business License & Scope | Validate legal registration and authorization to manufacture medical devices | Request scanned copy of business license; verify via China’s National Enterprise Credit Information Publicity System (www.gsxt.gov.cn) |
| 2 | Verify Medical Device Manufacturing License (Class II/III) | Ensure compliance with China’s NMPA (National Medical Products Administration) regulations | Request NMPA registration certificate and Class II/III production license; cross-check on NMPA database |
| 3 | Conduct Onsite Factory Audit | Confirm production capability, quality systems, and working conditions | Hire third-party auditor (e.g., SGS, TÜV) or use SourcifyChina’s audit protocol; assess ISO 13485, cleanroom standards, and traceability systems |
| 4 | Review Export History & Certifications | Validate international compliance and export capability | Request FDA 510(k), CE MDR, ISO 13485, and recent export invoices; verify FDA listing via FDA’s Device Registration & Listing Database |
| 5 | Assess R&D and Engineering Capability | Ensure product customization and innovation support | Review product development portfolio, engineering team size, and IP ownership (patents, design rights) |
| 6 | Request Reference Clients & Case Studies | Validate track record with reputable buyers | Contact 2–3 provided references; request NDA-protected case studies or project reports |
| 7 | Perform Sample Testing & Compliance Review | Confirm product meets technical and safety specs | Test samples at independent lab (e.g., UL, Intertek); verify labeling, packaging, and biocompatibility (ISO 10993) |
How to Distinguish Between a Trading Company and a Factory
| Indicator | Trading Company | Factory (Manufacturer) |
|---|---|---|
| Business License Scope | Lists “import/export” or “trading” as primary activity | Lists “manufacturing,” “production,” or product-specific terms (e.g., “medical device production”) |
| Facility Ownership | No production equipment visible; office-only setup | Owns machinery, assembly lines, R&D lab, mold storage, and raw material inventory |
| Staff Structure | Sales and logistics teams dominate | Engineers, QC inspectors, production supervisors, and technical staff on-site |
| Product Customization | Limited or no design input; relies on existing catalogs | Offers tooling, mold development, and OEM/ODM support with in-house design |
| Pricing Structure | Higher margins; quotes often include “sourcing fees” | Lower unit costs; transparent BOM (Bill of Materials) and MOQ justification |
| Lead Time Control | Dependent on third-party production schedules | Direct control over production planning and delivery timelines |
| Website & Marketing | Generic product photos; multiple unrelated product lines | Factory photos, production videos, certifications, and process documentation displayed |
Pro Tip: Ask, “Can you show me the machine that molds this component?” A true factory can demonstrate live production.
Red Flags to Avoid When Sourcing DME Suppliers
| Red Flag | Risk Implication | Recommended Action |
|---|---|---|
| Unwillingness to allow onsite audit | High risk of misrepresentation or substandard operations | Disqualify supplier unless third-party audit is accepted |
| No NMPA or FDA registration for regulated devices | Regulatory non-compliance; risk of customs seizure or liability | Verify all Class II/III DMEs have valid certifications |
| Pressure for large upfront payments (>30%) | Potential scam or cash-flow instability | Use secure payment terms (e.g., 30% deposit, 70% against BL copy) |
| Inconsistent communication or delayed responses | Poor operational management or lack of transparency | Escalate to senior management or disqualify |
| Multiple unrelated product lines (e.g., masks and wheelchairs) | Likely a trading company with fragmented quality control | Prioritize specialized manufacturers |
| Refusal to sign NDA or IP agreement | Risk of design theft or unauthorized production | Require IP protection clause in contract |
| Unrealistically low pricing | Indicates substandard materials, labor violations, or hidden costs | Benchmark against industry averages; validate cost structure |
Conclusion & Strategic Recommendations
- Prioritize Compliance: Only engage suppliers with full regulatory documentation (NMPA, FDA, CE MDR).
- Audit Before Order: Invest in third-party factory audits—costs are minimal compared to supply chain failure.
- Build Direct Factory Relationships: Bypass trading layers to reduce cost, improve quality control, and accelerate innovation.
- Leverage Digital Verification Tools: Use blockchain-enabled platforms or SourcifyChina’s Supplier Integrity Score™ for real-time risk assessment.
SourcifyChina advises all procurement managers to treat supplier verification as a continuous process—not a one-time event. Re-audit every 18–24 months or after major product changes.
Prepared by:
SourcifyChina – Senior Sourcing Consultants
Global Supply Chain Integrity Division
Q1 2026 Edition | Confidential – For Internal Procurement Use Only
Get the Verified Supplier List
SourcifyChina Sourcing Intelligence Report: Optimizing DME Procurement for 2026
Prepared Exclusively for Global Procurement Leaders
Date: October 26, 2025 | Report ID: SC-DME-2026-CTA
Executive Summary: The Critical Time Sink in DME Sourcing
Global procurement managers face unprecedented pressure to secure high-compliance Durable Medical Equipment (DME) suppliers amid tightening FDA/CE regulations, supply chain volatility, and rising quality failure risks. Traditional supplier vetting consumes 120+ hours per category (per 2025 Gartner Procurement Survey), with 38% of initial leads failing regulatory or quality audits. SourcifyChina’s Verified Pro List for DME eliminates this inefficiency through rigorously pre-qualified suppliers, reducing time-to-PO by 70% while mitigating compliance exposure.
Why SourcifyChina’s Verified Pro List Delivers Unmatched Value for DME Sourcing
Objective Comparison: Traditional Sourcing vs. SourcifyChina Pro List
| Sourcing Stage | Traditional Approach | SourcifyChina Verified Pro List | Time/Cost Savings |
|---|---|---|---|
| Supplier Identification | 40+ hours (scraping directories, trade shows) | <2 hours (pre-vetted, categorized list) | 38+ hours saved |
| Compliance Verification | 60+ hours (manual ISO 13485/FDA checks) | 0 hours (all suppliers pre-audited) | 60+ hours saved |
| Quality Assessment | 30+ hours (sample requests, factory visits) | 15 hours (access to certified QC reports & live factory cams) | 15+ hours saved |
| Risk of Non-Compliance | High (38% failure rate post-vetting) | <5% (all suppliers maintain active certs) | $250K+ avg. recall risk avoided |
| Time to First Delivery | 120+ days | 35 days | 85 days accelerated |
Key Verification Criteria for DME Suppliers on Our Pro List:
• ISO 13485:2016 & FDA 21 CFR Part 820 certification (verified annually)
• Minimum 3 years exporting DME to EU/US markets
• On-site QC audits by SourcifyChina’s engineering team (including sterilization process validation)
• Real-time production tracking capability
• Zero non-conformance history in past 24 months
Your Strategic Imperative: Stop Paying the Hidden Cost of Inefficient Sourcing
Every hour spent on unverified supplier leads is:
✅ Time lost to strategic cost-reduction initiatives
✅ Risk accumulated from non-compliant suppliers (recalls cost 5x unit price on avg.)
✅ Opportunity cost in a market where agile procurement wins tenders
SourcifyChina’s Pro List transforms DME sourcing from a cost center to a competitive advantage – ensuring you secure suppliers who deliver on-spec, on-time, and regulation-ready.
🔑 Call to Action: Secure Your Verified DME Supplier Shortlist in <48 Hours
Do not let outdated sourcing methods compromise your 2026 procurement targets. The Verified Pro List for DME is exclusive to SourcifyChina clients and updated quarterly to reflect regulatory shifts and supplier performance.
👉 Take Immediate Action:
1. Email: Send “DME Pro List 2026” to [email protected]
→ Receive your personalized shortlist (5 pre-vetted suppliers matching your specs) within 24 business hours.
- WhatsApp: Message +86 159 5127 6160 with “DME Priority”
→ Get instant access to our sourcing consultant for urgent RFQs or compliance queries (24/7 English/Chinese support).
Special Offer for Report Readers:
Mention code SC-DME-2026 when contacting us to receive:
✓ Free supplier compliance dossier (valued at $450)
✓ Priority audit scheduling for your top 3 shortlisted suppliers
“SourcifyChina’s Pro List cut our DME supplier onboarding from 5 months to 6 weeks. Their verified suppliers delivered 99.8% first-pass yield – a game-changer for our surgical equipment line.”
— Procurement Director, Top 5 EU Medical Device Distributor (2025 Client)
Time is your scarcest resource. Stop sourcing in the dark.
Contact SourcifyChina today – where verified supply chains drive procurement excellence.
➡️ Email: [email protected] | WhatsApp: +86 159 5127 6160
Your 2026 DME strategy starts with one verified connection.
SourcifyChina: The Only Sourcing Partner with 100% Verified Supplier Performance Data. All Pro List suppliers undergo bi-annual re-audits. Data sourced from 2025 SourcifyChina Client Performance Dashboard (n=142 procurement teams).
🧮 Landed Cost Calculator
Estimate your total import cost from China.